RaySearch Laboratories AB (publ) (RSLBF)

Market Cap	676.00M -4.2%
Revenue (ttm)	137.06M +10.5%
Net Income	23.26M +25.2%
EPS	0.68 +25.3%
Shares Out	n/a
PE Ratio	29.06
Forward PE	24.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7
Average Volume	1,698
Open	23.00
Previous Close	23.00
Day's Range	23.00 - 23.00
52-Week Range	22.50 - 37.36
Beta	1.07
RSI	43.19
Earnings Date	Feb 12, 2026

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2000
• Employees: 450
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSLBF

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK